Delix Therapeutics Announces Scientific & Strategic Advisory Board Appointments

PTSF62 – Senate Bill 519, Ketamine, and Psilocybin-producing Cicadas

Op-ed: UK Public Support Psilocybin Research & Rescheduling Despite Government Stance

Mindset Selects its Lead Clinical Candidate, MSP-1014, a Next Generation Psychedelic...

Field Trip Health Ltd. to Commence Trading on the Toronto Stock...

MINDCURE Successfully Completes First Stage of Manufacturing Synthetic Ibogaine for Use...

Silo Wellness Partners with Mushe Inc. to Establish First Legal Brick...

COMPASS Pathways and Kings College London publish cognition results from COMP360...

Psychedelics: A New Fountain of Youth?

MEC Announces Submission of Listing Statement to the CSE in Coordination...

Load more